IL6 and Cognitive impairment: A previous meta-analysis showed higher peripheral levels of soluble tumor necrosis factor receptor 2, monocyte chemoattractant protein-1, and IL-6, along with decreased IL-8 levels, in patients diagnosed with mild cognitive impairment when compared with controls (22).